The Kidney Cancer Association was founded in 1990 by Eugene P. Schonfeld and a small group of patients and doctors in Chicago, Illinois and has grown into an international non-profit organization. The KCA promotes scientific advances through two annual research symposiums and a robust grant program, participates in legislative advocacy, and seeks to be a source of education and resources for patients, caregivers, and anyone impacted by kidney cancer.
Our vision is to be the universal leader in finding the cure for kidney cancer.
Our mission is to be a global community dedicated to serving and empowering patients and caregivers, and leading change through advocacy, research, and education.
Kendall Monroe
Chief Advancement Officer
Houston, Texas
Dr. Salvatore La Rosa
Chief Scientific Officer
New York, New York
Ryan Cerezo
Development Manager
Lathrop, California
Radha Chitale
Senior Director of Communications
Washington, D.C.
Rosemary Chustak
Patient Liaison
Milwaukee, Wisconsin
Gabriela Galvan
Program Coordinator
Houston, Texas
M. Nathanial Haubrich
Director of Finance
Houston, Texas
Christine Kelly-Weaver
Executive Assistant to the President and CEO
Houston, Texas
Melissa Lopez
Gift Operations Associate
Punta Gorda, Florida
Amy Marbaugh
Director of Patient Programs
Cleveland, Ohio
Stephanie Shirley
Director of Advancement Services (Contractor)
Harrisburg, Pennsylvania
Damian Smith
Accountant
Houston, Texas
Jeanette Stensgaard
Director of Events (Contractor)
Denver, Colorado
Sarah Tuck
Program Manager
Langhorne, Pennsylvania
Maggie Valdes
Manager of Corporate Partnerships
Houston, Texas
Angela Washington
Director of Operations
Houston, Texas
Sarah Wood
Clinical Engagement Coordinator
Houston, Texas
Bradley Leibovich, MD, FACS (Chair)
Department of Urology, Mayo Clinic Cancer Center
Rochester, Minnesota
Laurence Albiges, MD, PhD
Professor, Institut Gustave Roussy
Paris, France
Mahul B. Amin, MD
Vice President, Lab Corp of America
San Diego, California
Ronald M. Bukowski, MD
Bukowski Consulting LLC
Cleveland, Ohio
Noah Buntman
Head of Supply Chain, Foundry Brands
Excelsior, Minnesota
Tessa Churchill, MD, MBA (Secretary)
Resident Physician, Anesthesiology,
Northwestern Medicine
Chicago, Illinois
Craig DePriester
Senior Vice President, Operations, Optum Care
Los Angeles, California
Daniel J. George, MD
Duke Cancer Institute
Durham, North Carolina
Jamie Graves
Director, State and Local Affairs, BP America
Chicago, Illinois
Ryan Natzke (Vice-Chair)
Chief External Affairs Officer, Marshfield Clinic Health System
Madison, Wisconsin
David Perry, Esq.
Retired, formerly a partner of K&L Gates LLP
Irvine, California
Shelley Robson
Senior Director of Trusts, Estates and Gift Planning, M.D. Anderson Cancer Center
Houston, Texas
Brian Shuch, MD
University of California, Los Angeles
Los Angeles, California
Joel Stern (Treasurer)
Retired, formerly CEO of the National Association of Minority and Women Owned Law Firms, Inc.
Kildeer, Illinois
Gretchen E. Vaughan
President and Chief Executive Officer, Kidney Cancer Association
Houston, Texas
Laura Wood, RN, MSN, OCN
Retired, formerly of the Cleveland Clinic Taussig Cancer Center
Cleveland, Ohio
Ruben Ybarra
Consultant/Project Manager, Shell
Houston, Texas
Laurence Albiges, MD, PhD
Professor, Institut Gustave Roussy
Paris, France
Mahul B. Amin, MD
Vice President, Lab Corp of America
San Diego, California
Axel Bex, MD, PhD
The Netherlands Cancer Institute
Amsterdam, The Netherlands
Ronald M. Bukowski, MD (Emeritus)
Emeritus Staff, Cleveland Clinic Taussig Cancer Center
Cleveland, Ohio
Matthew Campbell, MD, MS
M.D. Anderson Cancer Center
Houston, Texas
Daniel J. George, MD (Chair)
Duke Cancer Institute
Durham, North Carolina
Jose Karam, MD, FACS
M.D. Anderson Cancer Center
Houston, Texas
Bradley C. Leibovich, MD
Mayo Clinic Cancer Center
Rochester, Minnesota
Pavlos Msaouel, MD, PhD
M. D. Anderson Cancer Center
Houston, Texas
Sumanta Pal, MD
City of Hope
Duarte, California
Thomas Powles, MBBS, MRCP, MD
Barts Cancer Institute
London, England, UK
Sarah Psutka, MD
University of Washington
Seattle, Washington
Brian Rini, MD, FASCO
Vanderbilt-Ingram Cancer Center
Nashville, Tennessee
Brian Shuch, MD (Vice-Chair)
University of California, Los Angeles
Los Angeles, California
Eric Singer, MD, MA, MS, FACS, FASCO
Ohio State University
Columbus, Ohio
Walter M. Stadler, MD, FACP (Emeritus)
University of Chicago Medical Center
Chicago, Illinois
Nizar M. Tannir, MD, FACP (Emeritus)
M.D. Anderson Cancer Center
Houston, Texas
Tian Zhang, MD
UT Southwestern Medical Center
Dallas, Texas
*The Medical Steering Committee provides strategic guidance to KCA in the planning of its medical education activities as well as supervision of the content of its patient education programs and literature. This committee is also charged with responsibility for selection of members of the planning committees for all medical symposiums sponsored by KCA.
Julia Batten, APRN, MSN, MPH
Huntsman Cancer Institute
Salt Lake City, Utah
Reena Cherry, MS, PA-C
UC San Diego Health
San Diego, California
Patricia Fischer RN, MSN, OCN
Memorial Sloan-Kettering Cancer Center
New York, New York
Jan Jackson, RN
M.D. Anderson Cancer Center
Houston, Texas
Zita Lim, PA-C
M.D. Anderson Cancer Center
Houston, Texas
Lidia Lopez, DNP, MBA
UCLA Health
Los Angeles, California
Nancy Moldawer, RN, MSN (Co-Chair)
Cedars Sinai Medical Center
Los Angeles, California
Virginia J. Seery, MSN, RN, ANP-BC
Beth Israel Deaconess Medical Center
Boston, Massachusetts
Julia Stevens, PharmD, BCOP
Beth Israel Deaconess Medical Center
Boston, Massachusetts
Emily Wang, PharmD, BCOP
MD Anderson Cancer Center
Houston, Texas
Laura S. Wood, RN, MSN, OCN (Chair)
Retired, formerly of the Cleveland Clinic Taussig Cancer Center
Cleveland, Ohio
Nazy Zomorodian, NP
UCLA Health
Los Angeles, California
*Mission: The Clinical Advisory Board provides patients and caregivers in all stages of their illness accurate information in a manner that supports multiple learning modalities including written, audio, and visual.
Kathleen Campbell
Mineral, Virginia
Steven Edwards
New York, New York
John Ferrell
Austin, Texas
Sean Healy
Henrico, Virginia
Bruce Hill
Hudson Valley, New York
Vineeta Hiranandani
San Francisco, California
Ritchie Johnson
Houston, Texas
Benjamin Lundin
Granby, Connecticut
Matt McClain
San Juan Capistrano, California
Ryan Natzke (Chair)
Madison, Wisconsin
Annamaria Scaccia
Austin, Texas
Claudia Tatum
Bixby, Oklahoma
Marissa Willis
Blue Springs, Missouri
Salima Witt
San Diego, California
Peggy Zuckerman
Long Beach, California
*Mission: The Patient & Caregiver Advisory Council serves as the voice of the patient and provides the vital link between the patient community and the Kidney Cancer Association.
Work With Us
Check back later for more opportunities!
In his honor and with your generosity, together we will establish the
Dr. Christopher G. Wood Endowment. Learn more.
Dr. Christopher G. Wood, Chairman of the Kidney Cancer Association’s Board of Directors, died on November 3, 2021. Beyond the important role he played in championing the kidney cancer community, Dr. Wood was our dear friend, colleague, mentor, and leader. He will be greatly missed.
Courtesy of MD Anderson Cancer Center
Christopher Wood, M.D., Urology professor, passed away Nov. 3. He is remembered by his colleagues [at MD Anderson Cancer Center in Houston, Texas] as a surgeon with unwavering standards, a selfless mentor with boundless generosity, and, above all, a friend. He walked slowly, never in a hurry. He wasn’t shy, but spoke seldom, saving his words for when it mattered. And he brought a sense of fun and ease to almost every interaction.
“He was indescribably massive in every way: Intellect, personality, humor, skill, care and generosity,” says Neema Navai, M.D., Urology associate professor. “I hope for all of us it doesn’t take too many generations to see his equal again, but my heart tells me we never will.”
A dedicated clinician and researcher
In his more than 25 years at MD Anderson, Wood made innumerable contributions to the field of kidney cancer surgery and research. He was world renowned for his research around renal cell carcinoma. Outside of MD Anderson, he served as chair of the Kidney Cancer Association (KCA).
In an interview with KCA he once said, “I truly love helping people and there can be no greater gift to them than curing them of their cancer or making a positive impact on their outcome. I have the best job in the world.”
But it was a field he never intended to work in. Wood first came to MD Anderson as a fellow in 1995 and joined the faculty in 1998 with a dual appointment as an assistant professor in Urology and Cancer Biology. He told KCA he was originally hired to be the “prostate guy,” but at the time, the Urology department included only seven faculty, compared to 18 today. No one specialized in kidney cancer and many of those surgeries fell to him. He quickly discovered he loved treating the disease and eventually switched his research focus to match.
“Once Chris made up his mind to do something, nothing less than success was acceptable,” says Marshall Hicks, M.D., division head of Diagnostic Imaging.
As “the new kid,” Wood worked diligently, operating four days a week and spending Saturdays in his office writing protocols and catching up on administrative work. Even as a young faculty member, he was often asked by referring physicians to remove large tumors after other surgeons had tried and failed. Over the years, he focused on efficiency in the OR and helped expand kidney surgery services at MD Anderson. He was appointed deputy chair in 2008 and promoted to professor in 2010.
“Chris was an absolute force in the OR,” Navai says. “He could do things in 40 minutes that other surgeons needed three hours to complete, and he did it better than they ever could.”
He was known for playing heavy metal music and speaking his mind in the operating room. He never wavered in his direct approach but always remained kind.
“Chris leaves a legacy of master surgical skills that has changed where the bar is for the rest of us,” says John Davis, M.D., Urology professor.
A legacy focused on education
Wood harbored a passion for education and served as the departmental CME course chair, ran the urology agenda for a Surgery CME event and also hosted a conference for patients through the KCA.
“He had famous ways of getting good content out of the panelists – a mix of being serious and humorous,” Davis says. “He loved conference debates – preferably contentious and entertaining with figurative blood on the floor at the end.”
Wood was focused on faculty development. He had a steady pipeline of fellows known as “Wood fellows” who did basic lab research and contributed to high impact papers. He was dedicated to their development. often making personal sacrifices to bring them new opportunities.
“If I could describe him in two words, it’s unconditional generosity,” says Jose Karam, M.D., Urology associate professor and former fellow drawn to MD Anderson by Wood. “He never asked for anything in return.”
He remembered Wood often told them, “Your success is my success.”
“One of the things I admire most about him was his ability to put his own ego aside and elevate others around him,” says Brian Chapin, M.D., a Urology associate professor and former “Wood fellow.” “He was my mentor, my friend, my brother and, occasionally, my parent.”
A lasting impact
Outside of MD Anderson, Wood loved to travel, particularly to the Middle East or to Colorado when he stayed stateside. He loved to ski in the winter and play golf in the spring and summer. He was a Houston Texans season ticket holder for 20 years.
“He worked hard and played hard. Everything he did, he did full tilt,” Hicks says.
He was a loving husband to his wife Colleen and a dedicated father and friend to his children Chris Jr. and Sarah. For Wood, there was no division between his life in and outside of work. He welcomed many colleagues into his family and many of them grew close over the years. Carol Fourtunia, an administrative coordinator who worked with Wood for more than 20 years, says she considers the Woods her extended family.
“He was kind, so generous and I never knew him to say no to anything,” says Fourtunia. “He always wanted to help everyone.”
It wasn’t hard to see Wood’s impact in the days following his death. Many patients, societies and organizations from across the world reached out or released statements offering their condolences.
“The tremendous support and sympathy that we have received from individuals worldwide provided comfort and the reminder of the impact that Chris has had on the lives of so many,” says Colin Dinney, M.D., Urology chair. “At the same time, it also tells how much the world will miss him.”
The Kidney Cancer Association is a global community dedicated to serving and empowering patients, and leading change through advocacy, research, and education in order to be the universal leader in finding the cure for kidney cancer. Please contact us to learn more about kidney cancer or to get involved with our mission.
Mailing Address
Kidney Cancer Association
2777 Allen Parkway Suite 424
Houston, TX 77019
Donation Address
Kidney Cancer Association
PO Box 676226
Dallas, TX 75267-6226
Telephone & Fax
USA: (800) 850-9132
International: +1 847 332 1051
Email:
[email protected]
Patients: Patient Navigator Program
Donors: [email protected]
Physicians and Industry: [email protected]
Administrative: [email protected]